Trademarkia Logo

Canada

C$
B
ABANDONED SECTION 36

on 30 Nov 2023

Last Applicant/ Owned by

CHENGDU BRILLIANT PHARMACEUTICAL CO. LTD.

No.15, Gaopeng Avenue,High-tech Zone,ChengduSichuan

CN

Serial Number

2143147 filed on 24th May 2021

B

Trademark usage description

cultures of microorganisms for medical or veterinary use; medical dressings; anti-infectives for human use; pharmaceuticals for human use for the prev Read More

Vienna Information


26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

27 . 5 . 21

One letterUne lettre

29 . 1 . 4

BlueBleu

29 . 1 . 3

GreenVert

Classification Information


Class [005]
Cultures of microorganisms for medical or veterinary use; medical dressings; anti-infectives for human use; pharmaceuticals for human use for the prevention and treatment of cancer; pharmaceuticals for human use for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndrome; pharmaceuticals for human use for the treatment of cardiovascular disease; pharmaceuticals for human use for treating gastrointestinal disorders; pharmaceuticals for human use for the treatment of blood disorders; pharmaceuticals for human use for the treatment of respiratory diseases, disorders and infections; pharmaceuticals for human use for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; pharmaceuticals for human use for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceuticals for human use for the treatment of viral diseases, namely, herpes, hepatitis, acquired immune deficiency syndrome (aids); pharmaceuticals for human use for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceuticals for human use for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceuticals for human use for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceuticals for human use for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; plant and herb extracts for medicinal purposes, namely, for the treatment of colds and flu for human use; plant and herb extracts for pharmaceutical preparations for the treatment of colds and flu for human use; pharmaceuticals for human use for treating colds; medicines for human use for stimulating hair growth; medicines for human use for adjusting the menstrual cycle; medicines for human use for alleviating constipation; sulfonamides in the nature of medicines for human use; antiallergic medicines for human use; anti-epileptic pharmaceuticals for human use; inhaled pharmaceutical preparations for treating respiratory diseases and disorders for human use; pharmaceuticals for human use for ophthalmological use; pharmaceuticals for human use for reducing cholesterol; pharmaceuticals for human use for the prevention of osteoporosis; pharmaceuticals for human use for the relief of pain; pharmaceuticals for human use for the treatment of acne; pharmaceuticals for human use for the treatment of asthma; pharmaceuticals for human use for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceuticals for human use for the treatment of dental and oral diseases; pharmaceuticals for human use for the treatment of diseases, disorders and infections of the spinal cord systems and related cartilage and tissue; pharmaceuticals for human use for the treatment of drug and alcohol abuse; pharmaceuticals for human use for the treatment of heart rhythm disorders; pharmaceuticals for human use for the treatment of motion sickness; pharmaceuticals for human use for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, internet addiction, drug addiction; pharmaceuticals for human use for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; pharmaceuticals for human use for treating allergic rhinitis; pharmaceuticals for human use for treating the symptoms of radiation sickness; pharmaceuticals for human use for treatment or prevention of Covid-19, coronavirus disease, and respiratory diseases and disorders; antitussives for human use; antidepressants for human use; pharmaceuticals for human use for the treatment of headaches; pharmaceutical for human use for the treatment of erectile dysfunction; antipyretic analgesics for human use; antihemorrhoidal pharmaceuticals for human use; hormonal pharmaceuticals for human use, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone pharmaceuticals; diarrhea medication for human use; anaesthetics for human use; pesticides; antibiotics for veterinary purposes; hormones for veterinary purposes; pain relief medication for veterinary purposes; veterinary pharmaceuticals for periodontal diseases; veterinary pharmaceuticals for the treatment of arthritis, muscle soreness and sprains; veterinary pharmaceuticals for the treatment of infectious diseases in poultry; veterinary pharmaceuticals for the treatment of infectious diseases, namely, respiratory infections, eye infections, topical infections; veterinary pharmaceuticals for the treatment of parasites; veterinary pharmaceuticals for treatment of intestinal bacteria; veterinary vaccines; veterinary anaesthetics; albumin dietary supplements for medical purposes; depuratives for the body; oxygen for medical purposes; radioactive pharmaceutical preparations for in vivo diagnostic or therapeutic use.


Classification kind code

11

Mark Details


Serial Number

2143147

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 14
on 12th Sept 2023
Default Notice Sent
Submitted for opposition 22
on 24th Feb 2023
Search Recorded
Submitted for opposition 20
on 24th Feb 2023
Examiner's First Report
Submitted for opposition 223
on 24th Feb 2023
Total Provisional Refusal
Submitted for opposition 256
on 29th Aug 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 28th Oct 2021
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 27th Oct 2021
Created
Submitted for opposition 31
on 27th Oct 2021
Formalized
Submitted for opposition 30
on 24th May 2021
Filed
Submitted for opposition 228
on 24th May 2021
International Registration